{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:24:58Z","timestamp":1791404698474,"version":"4.3.3"},"reference-count":236,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/501100003825","name":"Hungarian Brain Research Program","doi-asserted-by":"publisher","award":["2017-1.2.1-NKP-2017-00002"],"award-info":[{"award-number":["2017-1.2.1-NKP-2017-00002"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Ministry of Human Capacities","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15- 2016-00060"],"award-info":[{"award-number":["GINOP-2.3.2-15- 2016-00060"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Ministry of Human Capacities","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00038"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00038"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Ministry of Human Capacities","doi-asserted-by":"publisher","award":["20391-3\/2018\/FEKUSTRAT"],"award-info":[{"award-number":["20391-3\/2018\/FEKUSTRAT"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2019,5,20]]},"abstract":"<jats:sec><jats:title\/><jats:p>Alzheimer\u2019s Disease (AD) is a form of progressive dementia involving cognitive impairment, loss of learning and memory. Different proteins (such as amyloid precursor protein (APP), \u03b2- amyloid (A\u03b2) and tau protein) play a key role in the initiation and progression of AD. We review the role of the most important proteins and peptides in AD pathogenesis. The structure, biosynthesis and physiological role of APP are shortly summarized. The details of trafficking and processing of APP to A\u03b2, the cytosolic intracellular A\u03b2 domain (AICD) and small soluble proteins are shown, together with other amyloid-forming proteins such as tau and \u03b1-synuclein (\u03b1-syn). Hypothetic physiological functions of A\u03b2 are summarized. The mechanism of conformational change, the formation and the role of neurotoxic amyloid oligomeric (oA\u03b2) are shown. The fibril formation process and the co-existence of different steric structures (U-shaped and S-shaped) of A\u03b2 monomers in mature fibrils are demonstrated. We summarize the known pathogenic and non-pathogenic mutations and show the toxic interactions of A\u03b2 species after binding to cellular receptors. Tau phosphorylation, fibrillation, the molecular structure of tau filaments and their toxic effect on microtubules are shown. Development of A\u03b2 and tau imaging in AD brain and CSF as well as blood biomarkers is shortly summarized. The most probable pathomechanisms of AD including the toxic effects of oA\u03b2 and tau; the three (biochemical, cellular and clinical) phases of AD are shown. Finally, the last section summarizes the present state of A\u03b2- and tau-directed therapies and future directions of AD research and drug development.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389203720666190103123434","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T13:57:23Z","timestamp":1546523843000},"page":"577-599","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Key Peptides and Proteins in Alzheimer\u2019s Disease"],"prefix":"10.2174","volume":"20","author":[{"given":"Botond","family":"Penke","sequence":"first","affiliation":[{"name":"Department of Medical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dom square 8, Szeged, H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Bog\u00e1r","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dom square 8, Szeged, H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Paragi","sequence":"additional","affiliation":[{"name":"MTA-SZTE Biomimetic Systems Research Group, University of Szeged, H-6720 Szeged, Dom square 8, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Gera","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dom square 8, Szeged, H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dom square 8, Szeged, H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/ijms17020189","volume":"17","author":"Kovacs G.G.","year":"2016","unstructured":"Kovacs GG. Molecular pathological classification of neurodegenerative diseases: Turning towards precision medicine.","journal-title":"Int J Mol Sci"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","volume":"6","author":"Rahimi J.","year":"2014","unstructured":"Rahimi J, Kovacs GG. Prevalence of mixed pathologies in the aging brain.","journal-title":"Alzheimers Res Ther"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuroscience.2014.03.045","volume":"269","author":"Kovacs G.G.","year":"2014","unstructured":"Kovacs GG, Adle-Biassette H, Milenkovic I, Cipriani S, Van Scheppingen J, Aronica E. Linking pathways in the developing and aging brain with neurodegeneration.","journal-title":"Neuroscience"},{"key":"ref=4","unstructured":""},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"Braak H.","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes.","journal-title":"Acta Neuropathol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"Thal D.R.","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD.","journal-title":"Neurology"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","volume":"6","author":"Kim W.S.","year":"2014","unstructured":"Kim WS, Kagedal K, Halliday GM. Alpha-synuclein biology in Lewy body diseases.","journal-title":"Alzheimers Res Ther"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"180036","DOI":"10.1038\/sdata.2018.36","volume":"5","author":"Ping L.","year":"2018","unstructured":"Ping L, Duong DM, Yin L, Gearing M, Lah JJ, Levey AI, Seyfried NT. Global quantitative analysis of the human brain proteome in Alzheimer\u2019s and Parkinson\u2019s Disease.","journal-title":"Sci Data"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/brain\/awx352","volume":"141","author":"Bereczki E.","year":"2018","unstructured":"Bereczki E, Branca RM, Francis PT, Pereira JB, Baek JH, Hortobagyi T, Winblad B, Ballard C, Lehtio J, Aarsland D. Synaptic markers of cognitive decline in neurodegenerative diseases: A proteomic approach.","journal-title":"Brain"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-018-0524-2","volume":"6","author":"Zhang Q.","year":"2018","unstructured":"Zhang Q, Ma C, Gearing M, Wang PG, Chin LS, Li L. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer\u2019s disease.","journal-title":"Acta Neuropathol Commun"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.3233\/JAD-2012-129026","volume":"33","author":"Caselli R.J.","year":"2013","unstructured":"Caselli RJ, Reiman EM. Characterizing the preclinical stages of Alzheimer\u2019s disease and the prospect of presymptomatic intervention.","journal-title":"J Alzheimers Dis"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/ejn.12261","volume":"37","author":"Boehm J.","year":"2013","unstructured":"Boehm J, Fernandes K, Leclerc N, Robitaille R. The neurobiology of aging and Alzheimer\u2019s disease: walking down the same road?","journal-title":"Eur J Neurosci"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"Duyckaerts C.","year":"2009","unstructured":"Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease.","journal-title":"Acta Neuropathol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.disamonth.2010.06.001","volume":"56","author":"Castellani R.J.","year":"2010","unstructured":"Castellani RJ, Rolston RK, Smith MA. Alzheimer disease.","journal-title":"Dis Mon"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4939-7558-7_18","volume":"1723","author":"Drummond E.","year":"2018","unstructured":"Drummond E, Nayak S, Pires G, Ueberheide B, Wisniewski T. Isolation of amyloid plaques and neurofibrillary tangles from archived Alzheimer\u2019s disease tissue using laser-capture microdissection for downstream proteomics.","journal-title":"Methods Mol Biol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","volume":"42","author":"Khachaturian Z.S.","year":"1985","unstructured":"Khachaturian ZS. Diagnosis of Alzheimers-disease.","journal-title":"Arch Neurol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"Mirra S.S.","year":"1991","unstructured":"Mirra SS, Heyman A, Mckeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Vanbelle G, Berg L. The consortium to establish a registry for Alzheimers-disease (Cerad). 2. standardization of the neuropathologic assessment of Alzheimers-disease.","journal-title":"Neurology"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)60607-8","volume":"42","author":"Smith M.A.","year":"1998","unstructured":"Smith MA. Alzheimer disease.","journal-title":"Int Rev Neurobiol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-170163","volume":"58","author":"Lacosta A.M.","year":"2017","unstructured":"Lacosta AM, Insua D, Badi H, Pesini P, Sarasa M. Neurofibrillary tangles of A beta(x-40) in Alzheimer\u2019s disease brains.","journal-title":"J Alzheimers Dis"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1523\/JNEUROSCI.3769-16.2017","volume":"37","author":"Marks S.M.","year":"2017","unstructured":"Marks SM, Lockhart SN, Baker SL, Jagust WJ. Tau and beta-amyloid are associated with medial temporal lobe structure, function, and memory encoding in normal aging.","journal-title":"J Neurosci"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cercor\/4.2.138","volume":"4","author":"Bouras C.","year":"1994","unstructured":"Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral-cortex of elderly patients - a quantitative-evaluation of a one-year autopsy population from a geriatric hospital.","journal-title":"Cereb Cortex"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0197-4580(93)90043-B","volume":"14","author":"Bennett D.A.","year":"1993","unstructured":"Bennett DA, Cochran EJ, Saper CB, Leverenz JB, Gilley DW, Wilson RS. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer\u2019s disease.","journal-title":"Neurobiol Aging"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0304-3940(89)90582-X","volume":"103","author":"Masliah E.","year":"1989","unstructured":"Masliah E, Terry RD, Deteresa RM, Hansen LA. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer-disease.","journal-title":"Neurosci Lett"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"Hardy J.","year":"1991","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the etiology of Alzheimers-disease.","journal-title":"Trends Pharmacol Sci"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2990.1987.tb00174.x","volume":"13","author":"Gray E.G.","year":"1987","unstructured":"Gray EG, Paulabarbosa M, Roher A. Alzheimers-disease - paired helical filaments and cytomembranes.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-014-1347-2","volume":"129","author":"Nhan H.S.","year":"2015","unstructured":"Nhan HS, Chiang K, Koo EH. The multifaceted nature of amyloid precursor protein and its proteolytic fragments: Friends and foes.","journal-title":"Acta Neuropathol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.devcel.2015.01.022","volume":"32","author":"van der Kant R.","year":"2015","unstructured":"van der Kant R, Goldstein LS. Cellular functions of the amyloid precursor protein from development to dementia.","journal-title":"Dev Cell"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2016.01.005","volume":"37","author":"Deyts C.","year":"2016","unstructured":"Deyts C, Thinakaran G, Parent AT. APP receptor? To be or not to be.","journal-title":"Trends Pharmacol Sci"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-6-27","volume":"6","author":"Zheng H.","year":"2011","unstructured":"Zheng H, Koo EH. Biology and pathophysiology of the amyloid precursor protein.","journal-title":"Mol Neurodegener"},{"key":"ref=30","unstructured":""},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fncel.2014.00410","volume":"8","author":"Stahl R.","year":"2014","unstructured":"Stahl R, Schilling S, Soba P, Rupp C, Hartmann T, Wagner K, Merdes G, Eggert S, Kins S. Shedding of APP limits its synaptogenic activity and cell adhesion properties.","journal-title":"Front Cell Neurosci"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"26991","DOI":"10.7554\/eLife.26991","volume":"6","author":"Puzzo D.","year":"2017","unstructured":"Puzzo D, Piacentini R, Fa M, Gulisano W, Li P. D.D.; Staniszewski, A.; Zhang, H.; Tropea, M.R.; Cocco, S.; Palmeri, A.; Fraser, P.; D\u2019Adamio, L.; Grassi, C.; Arancio, O. LTP and memory impairment caused by extracellular A beta and Tau oligomers is APP-dependent.","journal-title":"eLife"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1523\/JNEUROSCI.2009-17.2017","volume":"37","author":"Wang Z.M.","year":"2017","unstructured":"Wang ZM, Jackson RJ, Hong W, Taylor WM, Corbett GT, Moreno A, Liu W, Li SM, Frosch MP, Slutsky I, Young-Pearse TL, Spires-Jones TL, Walsh DM. Human brain-derived a beta oligomers bind to synapses and disrupt synaptic activity in a manner that requires APP.","journal-title":"J Neurosci"},{"key":"ref=34","first-page":"63","volume":"10","author":"Grimm M.O.W.","year":"2017","unstructured":"Grimm MOW, Mett J, Grimm HS, Hartmann T. APP function and lipids: A bidirectional link.","journal-title":"Front Mol Neurosci"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/molecules22101692","volume":"22","author":"Penke B.","year":"2017","unstructured":"Penke B, Bogar F, Fulop L. \u03b2-amyloid and the pathomechanisms of Alzheimer\u2019s disease: A comprehensive view.","journal-title":"Molecules"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41398-018-0231-6","volume":"8","author":"Elliott C.","year":"2018","unstructured":"Elliott C, Rojo AI, Ribe E, Broadstock M, Xia W, Morin P, Semenov M, Baillie G, Cuadrado A, Al-Shawi R, Ballard CG, Simons P, Killick R. A role for APP in Wnt signalling links synapse loss with beta-amyloid production.","journal-title":"Transl Psychiatry"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s13311-018-0656-x","volume":"15","author":"Belaidi A.A.","year":"2018","unstructured":"Belaidi AA, Gunn AP, Wong BX, Ayton S, Appukuttan AT, Roberts BR, Duce JA, Bush AI. Marked age-related changes in brain iron homeostasis in amyloid protein precursor knockout mice.","journal-title":"Neurotherapeutics"},{"key":"ref=38","first-page":"269","volume":"23","author":"Norstrom E.","year":"2017","unstructured":"Norstrom E. Metabolic Processing of the amyloid precursor protein -- new pieces of the Alzheimer\u2019s puzzle.","journal-title":"Discov Med"},{"key":"ref=39","unstructured":""},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pneurobio.2008.05.002","volume":"85","author":"Muller T.","year":"2008","unstructured":"Muller T, Meyer HE, Egensperger R, Marcus K. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer\u2019s disease.","journal-title":"Prog Neurobiol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13041-014-0054-1","volume":"7","author":"Tam J.H.K.","year":"2014","unstructured":"Tam JHK, Seah C, Pasternak SH. The amyloid precursor protein is rapidly transported from the golgi apparatus to the lysosome and where it is processed into beta-amyloid.","journal-title":"Mol Brain"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/359322a0","volume":"359","author":"Haass C.","year":"1992","unstructured":"Haass C, Schlossmacher MG, Hung AY, Vigopelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ. Amyloid beta-peptide is produced by cultured-cells during normal metabolism.","journal-title":"Nature"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fnmol.2017.00294","volume":"10","author":"Wang X.","year":"2017","unstructured":"Wang X, Zhou X, Li GY, Zhang Y, Wu YL, Song WH. Modifications and trafficking of APP in the pathogenesis of Alzheimer\u2019s disease.","journal-title":"Front Mol Neurosci"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","volume":"96","author":"Lammich S.","year":"1999","unstructured":"Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F. Constitutive and regulated alpha-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by a disintegrin metalloprotease.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/emboj.2010.167","volume":"29","author":"Kuhn P.H.","year":"2010","unstructured":"Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW, Kremmer E, Rossner S, Lichtenthaler SF. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons.","journal-title":"EMBO J"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","volume":"120","author":"Chasseigneaux S.","year":"2012","unstructured":"Chasseigneaux S, Allinquant B. Functions of A\u03b2, sAPP\u03b1 and sAPP\u03b2: Similarities and differences.","journal-title":"J Neurochem"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"006270","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"Haass C.","year":"2012","unstructured":"Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-2011-101065","volume":"25","author":"Haapasalo A.","year":"2011","unstructured":"Haapasalo A, Kovacs DM. The many substrates of presenilin\/gamma-secretase.","journal-title":"J Alzheimers Dis"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-pharmtox-010814-124309","volume":"55","author":"De Strooper B.","year":"2015","unstructured":"De Strooper B, Gutierrez LC. Learning by failing: Ideas and concepts to tackle gamma-secretases in Alzheimer\u2019s disease and beyond.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature14864","volume":"526","author":"Willem M.","year":"2015","unstructured":"Willem M, Tahirovic S, Busche MA, Ovsepian SV, Chafai M, Kootar S, Hornburg D, Evans LDB, Moore S, Daria A, Hampel H, Muller V, Giudici C, Nuscher B, Wenninger-Weinzierl A, Kremmer E, Heneka MT, Thal DR, Giedraitis V, Lannfelt L, Muller U, Livesey FJ, Meissner F, Herms J, Konnerth A, Marie H, Haass C. \u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus.","journal-title":"Nature"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1523\/JNEUROSCI.16-03-00899.1996","volume":"16","author":"Simons M.","year":"1996","unstructured":"Simons M, DeStrooper B, Multhaup G, Tienari PJ, Dotti CG, Beyreuther K. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons.","journal-title":"J Neurosci"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1038\/ncomms9762","volume":"6","author":"Zhang Z.T.","year":"2015","unstructured":"Zhang ZT, Song MK, Liu X, Kang SS, Duong DM, Seyfried NT, Cao XB, Cheng LM, Sun YE, Yu SP, Jia JP, Levey AI, Ye KQ. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer\u2019s disease.","journal-title":"Nat Commun"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"33304","DOI":"10.1074\/jbc.M112.395608","volume":"287","author":"Bien J.","year":"2012","unstructured":"Bien J, Jefferson T, Causevic M, Jumpertz T, Munter L, Multhaup G, Weggen S, Becker-Pauly C, Pietrzik CU. The metalloprotease meprin beta generates amino terminal-truncated amyloid beta peptide species.","journal-title":"J Biol Chem"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jnc.13932","volume":"140","author":"Salminen A.","year":"2017","unstructured":"Salminen A, Kauppinen M, Kaamiranta K. Hypoxia\/ischemia activate processing of amyloid precursor protein: Impact of vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease.","journal-title":"J Neurochem"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","volume":"38","author":"Chong F.P.","year":"2018","unstructured":"Chong FP, Ng KY, Koh RY, Chye SM. Tau proteins and tauopathies in Alzheimer\u2019s disease.","journal-title":"Cell Mol Neurobiol"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","volume":"33","author":"Goedert M.","year":"2010","unstructured":"Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases.","journal-title":"Trends Neurosci"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000283475","volume":"7","author":"Gotz J.","year":"2010","unstructured":"Gotz J, Lim YA, Ke YD, Eckert A, Ittner LM. Dissecting toxicity of tau and beta-amyloid.","journal-title":"Neurodegener Dis"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"Kovacs G.G.","year":"2015","unstructured":"Kovacs GG. Invited review: Neuropathology of tauopathies: Principles and practice.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"006247","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"Mandelkow E.M.","year":"2012","unstructured":"Mandelkow EM, Mandelkow E. Biochemistry and cell biology of tau protein in neurofibrillary degeneration.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1371\/journal.pbio.1000034","volume":"7","author":"Mukrasch M.D.","year":"2009","unstructured":"Mukrasch MD, Bibow S, Korukottu J, Jeganathan S, Biernat J, Griesinger C, Mandelkow E, Zweckstetter M. Structural polymorphism of 441-residue tau at single residue resolution.","journal-title":"PLoS Biol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1073\/pnas.88.6.2288","volume":"88","author":"Crowther R.A.","year":"1991","unstructured":"Crowther RA. Straight and paired helical filaments in Alzheimer disease have a common structural unit.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"Fitzpatrick A.W.P.","year":"2017","unstructured":"Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, Crowther RA, Ghetti B, Goedert M, Scheres SHW. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease.","journal-title":"Nature"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"Goedert M.","year":"1989","unstructured":"Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein-tau - sequences and localization in neurofibrillary tangles of Alzheimers-disease.","journal-title":"Neuron"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jmb.2017.03.018","volume":"429","author":"Duan A.R.","year":"2017","unstructured":"Duan AR, Jonasson EM, Alberico EO, Li CL, Scripture JP, Miller RA, Alber MS, Goodson HV. Interactions between tau and different conformations of tubulin: implications for tau function and mechanism.","journal-title":"J Mol Biol"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0959-4388(95)80058-1","volume":"5","author":"Brady S.T.","year":"1995","unstructured":"Brady ST, Sperry AO. Biochemical and functional diversity of microtubule motors in the nervous system.","journal-title":"Curr Opin Neurobiol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-9-43","volume":"9","author":"Moussaud S.","year":"2014","unstructured":"Moussaud S, Jones DR, Moussaud-Lamodiere EL, Delenclos M, Ross OA, McLean PJ. Alpha-synuclein and tau: Teammates in neurodegeneration?","journal-title":"Mol Neurodegener"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nsmb.3433","volume":"24","author":"Zhang Z.T.","year":"2017","unstructured":"Zhang ZT, Kang SS, Liu X, Ahn EH, Zhang ZH, He L, Iuvone PM, Duong DM, Seyfried NT, Benskey MJ, Manfredsson FP, Jin LJ, Sun YE, Wang JZ, Ye KQ. Asparagine endopeptidase cleaves alpha-synuclein and mediates pathologic activities in Parkinson\u2019s disease.","journal-title":"Nat Struct Mol Biol"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1523\/JNEUROSCI.0581-12.2012","volume":"32","author":"Larson M.E.","year":"2012","unstructured":"Larson ME, Sherman MA, Greimel S, Kuskowski M, Schneider JA, Bennett DA, Lesne SE. Soluble alpha-synuclein is a novel modulator of Alzheimer\u2019s disease pathophysiology.","journal-title":"J Neurosci"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-002-0545-5","volume":"104","author":"Yokota O.","year":"2002","unstructured":"Yokota O, Terada S, Ishizu H, Tsuchiya K, Kitamura Y, Ikeda K, Ueda K, Kuroda S. NACP\/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).","journal-title":"Acta Neuropathol"},{"key":"ref=70","first-page":"00592","volume":"2","author":"Diao J.J.","year":"2013","unstructured":"Diao JJ, Burre J, Vivona S, Cipriano DJ, Sharma M, Kyoung M, Sudhof TC, Brunger AT. Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2\/VAMP2.","journal-title":"eLife"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1074\/jbc.M102981200","volume":"277","author":"Alim M.A.","year":"2002","unstructured":"Alim MA, Hossain MS, Arima K, Takeda K, Izumiyama Y, Nakamura M, Kaji H, Shinoda T, Hisanaga S, Ueda K. Tubulin seeds alpha-synuclein fibril formation.","journal-title":"J Biol Chem"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"Bartels T.","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ. Alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.","journal-title":"Nature"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"Spillantini M.G.","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies.","journal-title":"Nature"},{"key":"ref=74","first-page":"321","volume":"17","author":"Sadigh-Eteghad S.","year":"2012","unstructured":"Sadigh-Eteghad S, Talebi M, Farhoudi M. Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer\u2019s disease A meta-analysis.","journal-title":"Neurosciences"},{"key":"ref=75","first-page":"586","volume":"45","author":"Sepehrnia B.","year":"1989","unstructured":"Sepehrnia B, Kamboh MI, Adamscampbell LL, Bunker CH, Nwankwo M, Majumder PP, Ferrell RE. Genetic-studies of human apolipoproteins. 10. the effect of the apolipoprotein-e polymorphism on quantitative levels of lipoproteins in nigerian blacks.","journal-title":"Am J Hum Genet"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","volume":"17","author":"Notkola I.L.","year":"1998","unstructured":"Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto A, Nissinen A. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer\u2019s disease.","journal-title":"Neuroepidemiology"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/15672050113109990156","volume":"10","author":"Hauser P.S.","year":"2013","unstructured":"Hauser PS, Ryan RO. Impact of apolipoprotein E on Alzheimer\u2019s disease.","journal-title":"Curr Alzheimer Res"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41398-018-0221-8","volume":"8","author":"Stocker H.","year":"2018","unstructured":"Stocker H, Mollers T, Perna L, Brenner H. The genetic risk of Alzheimer\u2019s disease beyond APOE epsilon 4: Systematic review of Alzheimer\u2019s genetic risk scores.","journal-title":"Transl Psychiatry"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","volume":"37","author":"Yu J.T.","year":"2014","unstructured":"Yu JT, Tan L, Hardy J. Apolipoprotein E in Alzheimer\u2019s disease: An update.","journal-title":"Annu Rev Neurosci"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2015.12.004","volume":"137","author":"Han S.H.","year":"2016","unstructured":"Han SH, Park JC, Mook-Jung I. Amyloid beta-interacting partners in Alzheimer\u2019s disease: From accomplices to possible therapeutic targets.","journal-title":"Prog Neurobiol"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fnagi.2018.00180","volume":"10","author":"Brandon J.A.","year":"2018","unstructured":"Brandon JA, Farmer BC, Williams HC, Johnson LA. APOE and Alzheimer\u2019s disease: Neuroimaging of metabolic and cerebrovascular dysfunction.","journal-title":"Front Aging Neurosci"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neurobiolaging.2012.10.011","volume":"34","author":"Wolf A.B.","year":"2013","unstructured":"Wolf AB, Caselli RJ, Reiman EM, Valla J. APOE and neuroenergetics: An emerging paradigm in Alzheimer\u2019s disease.","journal-title":"Neurobiol Aging"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/jcbfm.2014.172","volume":"35","author":"Alata W.","year":"2015","unstructured":"Alata W, Ye Y, St-Amour I, Vandal M, Calon F. Human apolipoprotein E epsilon 4 expression impairs cerebral vascularization and blood-brain barrier function in mice.","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"Bell R.D.","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu ZH, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV. Apolipoprotein E controls cerebrovascular integrity cyclophilin A.","journal-title":"Nature"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-016-0231-9","volume":"9","author":"Nielsen H.M.","year":"2017","unstructured":"Nielsen HM, Chen KW, Lee W, Chen YH, Bauer RJ, Reiman E, Caselli R, Bu GJ. Peripheral apoE isoform levels in cognitively normal APOE epsilon 3\/epsilon 4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.","journal-title":"Alzheimers Res Ther"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.R075481","volume":"58","author":"Huynh T.V.","year":"2017","unstructured":"Huynh TV, Davis AA, Ulrich JD, Holtzman DM. Apolipoprotein E and Alzheimer\u2019s disease: the influence of apolipoprotein E on amyloid-beta and other amyloidogenic proteins.","journal-title":"J Lipid Res"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"Holtzman D.M.","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"10539","DOI":"10.1523\/JNEUROSCI.22-24-10539.2002","volume":"22","author":"Buttini M.","year":"2002","unstructured":"Buttini M, Yu GQ, Shockley K, Huang YD, Jones B, Masliah E, Mallory M, Yeo T, Longo FM, Mucke L. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.","journal-title":"J Neurosci"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"Fagan A.M.","year":"2002","unstructured":"Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease.","journal-title":"Neurobiol Dis"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"Kim J.","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer\u2019s disease.","journal-title":"Neuron"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ajpath.2013.01.034","volume":"182","author":"Kuszczyk M.A.","year":"2013","unstructured":"Kuszczyk MA, Sanchez S, Pankiewicz J, Kim J, Duszczyk M, Guridi M, Asuni AA, Sullivan PM, Holtzman DM, Sadowski MJ. Blocking the interaction between apolipoprotein E and A beta reduces intraneuronal accumulation of A beta and inhibits synaptic degeneration.","journal-title":"Am J Pathol"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1113\/jphysiol.2013.257527","volume":"592","author":"Berridge M.J.","year":"2014","unstructured":"Berridge MJ. Calcium regulation of neural rhythms, memory and Alzheimer\u2019s disease.","journal-title":"J Physiol"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"728571","DOI":"10.5402\/2012\/728571","volume":"2012","author":"Ferreira A.","year":"2012","unstructured":"Ferreira A. Calpain dysregulation in Alzheimer\u2019s disease.","journal-title":"ISRN Biochem"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1042\/BST20130201","volume":"41","author":"McBrayer M.","year":"2013","unstructured":"McBrayer M, Nixon RA. Lysosome and calcium dysregulation in Alzheimer\u2019s disease: Partners in crime.","journal-title":"Biochem Soc Trans"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40478-016-0299-2","volume":"4","author":"Kurbatskaya K.","year":"2016","unstructured":"Kurbatskaya K, Phillips EC, Croft CL, Dentoni G, Hughes MM, Wade MA, Al-Sarraj S, Troakes C, O\u2019Neill MJ, Perez-Nievas BG, Hanger DP, Noble W. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer\u2019s disease brain.","journal-title":"Acta Neuropathol Commun"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.02.004","volume":"105","author":"Yamashima T.","year":"2013","unstructured":"Yamashima T. Reconsider Alzheimer\u2019s disease by the \u2018calpain-cathepsin hypothesis\u2019-A perspective review.","journal-title":"Prog Neurobiol"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.1038\/s41598-018-31073-6","volume":"8","author":"Ahmad F.","year":"2018","unstructured":"Ahmad F, Das D, Kommaddi RP, Diwakar L, Gowaikar R, Rupanagudi KV, Bennett DA, Ravindranath V. Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer\u2019s disease mice and correlates with memory deficits in human subjects.","journal-title":"Sci Rep"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fninf.2018.00026","volume":"12","author":"Ashraf J.","year":"2018","unstructured":"Ashraf J, Ahmad J, Ali A, Ul-Haq Z. Analyzing the behavior of neuronal pathways in Alzheimer\u2019s disease using petri net modeling approach.","journal-title":"Front Neuroinform"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.aah6205","volume":"354","author":"Ittner A.","year":"2016","unstructured":"Ittner A, Chua SW, Bertz J, Volkerling A, van der Hoven J, Gladbach A, Przybyla M, Bi M, van Hummel A, Stevens CH, Ippati S, Suh LS, Macmillan A, Sutherland G, Kril JJ, Silva APG, Mackay J, Poljak A, Delerue F, Ke YD, Ittner LM. Site-specific phosphorylation of tau inhibits amyloid-beta toxicity in Alzheimer\u2019s mice.","journal-title":"Science"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2017.06.004","volume":"83","author":"Nygaard H.B.","year":"2018","unstructured":"Nygaard HB. Targeting fyn kinase in Alzheimer\u2019s disease.","journal-title":"Biol Psychiatry"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2164-14-290","volume":"14","author":"Tharp W.G.","year":"2013","unstructured":"Tharp WG, Sarkar IN. Origins of amyloid-beta.","journal-title":"BMC Genomics"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fnagi.2018.00118","volume":"10","author":"Brothers H.M.","year":"2018","unstructured":"Brothers HM, Gosztyla ML, Robinson SR. The physiological roles of amyloid-beta peptide hint at new ways to treat Alzheimer\u2019s disease.","journal-title":"Front Aging Neurosci"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1371\/journal.pone.0009505","volume":"5","author":"Soscia S.J.","year":"2010","unstructured":"Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD. The Alzheimer\u2019s disease-associated amyloid beta-protein is an antimicrobial peptide.","journal-title":"PLoS One"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1038\/s41598-017-10422-x","volume":"7","author":"Wildburger N.C.","year":"2017","unstructured":"Wildburger NC, Esparza TJ, LeDuc RD, Fellers RT, Thomas PM, Cairns NJ, Kelleher NL, Bateman RJ, Brody DL. Diversity of amyloid-beta proteoforms in the Alzheimer\u2019s disease brain.","journal-title":"Sci Rep"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"Masters C.L.","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, Mcdonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer-disease and down syndrome.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1021\/acs.biochem.5b01259","volume":"55","author":"Roche J.","year":"2016","unstructured":"Roche J, Shen Y, Lee JH, Ying J, Bax A. Monomeric Abeta(1-40) and Abeta(1-42) peptides in solution adopt very similar ramachandran map distributions that closely resemble random coil.","journal-title":"Biochemistry"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1529\/biophysj.105.079186","volume":"91","author":"Wei G.H.","year":"2006","unstructured":"Wei GH, Shea JE. Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide.","journal-title":"Biophys J"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1021\/jacs.7b08089","volume":"139","author":"Zheng W.H.","year":"2017","unstructured":"Zheng WH, Tsai MY, Wolynes PG. Comparing the aggregation free energy landscapes of amyloid beta(1-42) and amyloid beta(1-40).","journal-title":"J Am Chem Soc"},{"key":"ref=109","unstructured":"109(Pt B), 191-200."},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"Chiti F.","year":"2017","unstructured":"Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: A summary of progress over the last decade.","journal-title":"Annu Rev Biochem"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"Viola K.L.","year":"2015","unstructured":"Viola KL, Klein WL. Amyloid beta oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis.","journal-title":"Acta Neuropathol"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","volume":"24","author":"Klein W.L.","year":"2001","unstructured":"Klein WL, Krafft GA, Finch CE. Targeting small A beta oligomers: The solution to an Alzheimer\u2019s disease conundrum?","journal-title":"Trends Neurosci"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"Lambert M.P.","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. Diffusible, nonfibrillar ligands derived from A beta(1-42) are potent central nervous system neurotoxins.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/alzrt226","volume":"5","author":"Hayden E.Y.","year":"2013","unstructured":"Hayden EY, Teplow DB. Amyloid beta-protein oligomers and Alzheimer\u2019s disease.","journal-title":"Alzheimers Res Ther"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"006338","DOI":"10.1101\/cshperspect.a006338","volume":"2","author":"Mucke L.","year":"2012","unstructured":"Mucke L, Selkoe DJ. Neurotoxicity of amyloid beta-protein: Synaptic and network dysfunction.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","volume":"96","author":"Ferreira S.T.","year":"2011","unstructured":"Ferreira ST, Klein WL. The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer\u2019s disease.","journal-title":"Neurobiol Learn Mem"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"Kayed R.","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.","journal-title":"Science"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","volume":"100","author":"Gong Y.","year":"2003","unstructured":"Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL. Alzheimer\u2019s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"Walsh D.M.","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation","journal-title":"Nature"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"24765","DOI":"10.1074\/jbc.M111.329763","volume":"287","author":"Ladiwala A.R.A.","year":"2012","unstructured":"Ladiwala ARA, Litt J, Kane RS, Aucoin DS, Smith SO, Ranjan S, Davis J, Van Nostrand WE, Tessier PM. Conformational differences between two amyloid beta oligomers of similar size and dissimilar toxicity.","journal-title":"J Biol Chem"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-6606-5-25","volume":"5","author":"Klyubin I.","year":"2012","unstructured":"Klyubin I, Cullen WK, Hu NW, Rowan MJ. Alzheimer\u2019s disease A beta assemblies mediating rapid disruption of synaptic plasticity and memory.","journal-title":"Mol Brain"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1111\/febs.14587","volume":"285","author":"Choi M.L.","year":"2018","unstructured":"Choi ML, Gandhi S. Crucial role of protein oligomerization in the pathogenesis of Alzheimer\u2019s and Parkinson\u2019s diseases.","journal-title":"FEBS J"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-160007","volume":"53","author":"Pickett E.K.","year":"2016","unstructured":"Pickett EK, Koffie RM, Wegmann S, Henstridge CM, Herrmann AG, Colom-Cadena M, Lleo A, Kay KR, Vaught M, Soberman R, Walsh DM, Hyman BT, Spires-Jones TL. Non-fibrillar oligomeric amyloid-beta within synapses.","journal-title":"J Alzheimers Dis"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","volume":"119","author":"Gouras G.K.","year":"2010","unstructured":"Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer\u2019s disease.","journal-title":"Acta Neuropathol"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1073\/pnas.0409336102","volume":"102","author":"Georganopoulou D.G.","year":"2005","unstructured":"Georganopoulou DG, Chang L, Nam JM, Thaxton CS, Mufson EJ, Klein WL, Mirkin CA. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer\u2019s disease.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1074\/jbc.M507892200","volume":"281","author":"Oddo S.","year":"2006","unstructured":"Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, LaFerla FM. Temporal profile of amyloid-beta (A beta) oligomerization in an in vivo model of Alzheimer disease - A link between A beta and tau pathology.","journal-title":"J Biol Chem"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nchembio.283","volume":"6","author":"Campioni S.","year":"2010","unstructured":"Campioni S, Mannini B, Zampagni M, Pensalfini A, Parrini C, Evangelisti E, Relini A, Stefani M, Dobson CM, Cecchi C, Chiti F. A causative link between the structure of aberrant protein oligomers and their toxicity.","journal-title":"Nat Chem Biol"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1083\/jcb.201612165","volume":"216","author":"Hamdan N.","year":"2017","unstructured":"Hamdan N, Kritsiligkou P, Grant CM. ER stress causes widespread protein aggregation and prion formation.","journal-title":"J Cell Biol"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/acschemneuro.5b00324","volume":"7","author":"Horrocks M.H.","year":"2016","unstructured":"Horrocks MH, Lee SF, Gandhi S, Magdalinou NK, Chen SW, Devine MJ, Tosatto L, Kjaergaard M, Beckwith JS, Zetterberg H, Iljina M, Cremades N, Dobson CM, Wood NW, Klenerman D. Single-molecule imaging of individual amyloid protein aggregates in human biofluids.","journal-title":"ACS Chem Neurosci"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"Lesne S.","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH. A specific amyloid-beta protein assembly in the brain impairs memory.","journal-title":"Nature"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/s41598-017-02370-3","volume":"7","author":"Wolff M.","year":"2017","unstructured":"Wolff M, Zhang-Haagen B, Decker C, Barz B, Schneider M, Biehl R, Radulescu A, Strodel B, Willbold D, Nagel-Steger L. Abeta42 pentamers\/hexamers are the smallest detectable oligomers in solution.","journal-title":"Sci Rep"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nsmb.1799","volume":"17","author":"Ahmed M.","year":"2010","unstructured":"Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, Elliott JI, Van Nostrand WE, Smith SO. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils.","journal-title":"Nat Struct Mol Biol"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ab.2015.12.021","volume":"498","author":"Shigemitsu Y.","year":"2016","unstructured":"Shigemitsu Y, Iwaya N, Goda N, Matsuzaki M, Tenno T, Narita A, Hoshi M, Hiroaki H. Nuclear magnetic resonance evidence for the dimer formation of beta amyloid peptide 1-42 in 1,1,1,3,3,3-hexafluoro-2-propanol.","journal-title":"Anal Biochem"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.talanta.2016.12.011","volume":"165","author":"Brinet D.","year":"2017","unstructured":"Brinet D, Gaie-Levrel F, Delatour V, Kaffy J, Ongeri S, Taverna M. monitoring of amyloid beta-peptide oligomerization by Electrospray differential mobility analysis: An alternative tool to evaluate Alzheimer\u2019s disease drug candidates.","journal-title":"Talanta"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"E2415","DOI":"10.3390\/ijms19082415","volume":"19","author":"Acosta D.M.A.V.","year":"2018","unstructured":"Acosta DMAV, Vega BC, Basurto JC, Morales LGF, Hernandez MCR. Recent advances by and studies of amyloid-\u03b2 1-42 fibril depicted a s-shape conformation.","journal-title":"Int J Mol Sci"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuron.2015.03.017","volume":"86","author":"Tycko R.","year":"2015","unstructured":"Tycko R. Amyloid polymorphism: Structural basis and neurobiological relevance.","journal-title":"Neuron"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"Chiti F.","year":"2006","unstructured":"Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease.","journal-title":"Annu Rev Biochem"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3233\/JAD-170230","volume":"59","author":"Galzitskaya O.V.","year":"2017","unstructured":"Galzitskaya OV, Selivanova OM. Rosetta stone for amyloid fibrils: The key role of ring-like oligomers in amyloidogenesis.","journal-title":"J Alzheimers Dis"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"Cohen S.I.","year":"2013","unstructured":"Cohen SI, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M, Dobson CM, Knowles TP. Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00401-016-1565-x","volume":"131","author":"Kovacs G.G.","year":"2016","unstructured":"Kovacs GG, Lutz MI, Ricken G, Strobel T, Hoftberger R, Preusser M, Regelsberger G, Honigschnabl S, Reiner A, Fischer P, Budka H, Hainfellner JA. Dura mater is a potential source of A beta seeds.","journal-title":"Acta Neuropathol"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jsb.2016.03.020","volume":"194","author":"Dovidchenko N.V.","year":"2016","unstructured":"Dovidchenko NV, Glyakina AV, Selivanova OM, Grigorashvili EI, Suvorina MY, Dzhus UF, Mikhailina AO, Shiliaev NG, Marchenkov VV, Surin AK, Galzitskaya OV. One of the possible mechanisms of amyloid fibrils formation based on the sizes of primary and secondary folding nuclei of Abeta40 and Abeta42.","journal-title":"J Struct Biol"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0076-6879(99)09033-3","volume":"309","author":"Nielsen E.H.","year":"1999","unstructured":"Nielsen EH, Nybo M, Svehag SE. Electron microscopy of prefibrillar structures and amyloid fibrils.","journal-title":"Methods Enzymol"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"8768","DOI":"10.1002\/chem.201601701","volume":"22","author":"Barz B.","year":"2016","unstructured":"Barz B, Strodel B. Understanding amyloid-beta oligomerization at the molecular level: The role of the fibril surface.","journal-title":"Chemistry"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12551-017-0289-z","volume":"9","author":"Linse S.","year":"2017","unstructured":"Linse S. Monomer-dependent secondary nucleation in amyloid formation.","journal-title":"Biophys Rev"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1039\/C8CC02204F","volume":"54","author":"Tornquist M.","year":"2018","unstructured":"Tornquist M, Michaels TCT, Sanagavarapu K, Yang X, Meisl G, Cohen SIA, Knowles TPJ, Linse S. Secondary nucleation in amyloid formation.","journal-title":"Chem Commun (Camb)"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1021\/ja311963f","volume":"135","author":"Qiang W.","year":"2013","unstructured":"Qiang W, Kelley K, Tycko R. Polymorph-specific kinetics and thermodynamics of beta-amyloid fibril growth.","journal-title":"J Am Chem Soc"},{"key":"ref=147","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0065-3233(08)60320-4","volume":"50","author":"Sunde M.","year":"1997","unstructured":"Sunde M, Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction.","journal-title":"Adv Protein Chem"},{"key":"ref=148","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.2174\/1381612822666160518141911","volume":"22","author":"Ruggeri F.S.","year":"2016","unstructured":"Ruggeri FS, Habchi J, Cerreta A, Dietler G. AFM-based single molecule techniques: unraveling the amyloid pathogenic species.","journal-title":"Curr Pharm Des"},{"key":"ref=149","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/acs.jpcb.7b10765","volume":"122","author":"Lomont J.P.","year":"2018","unstructured":"Lomont JP, Rich KL, Maj M, Ho JJ, Ostrander JS, Zanni MT. Spectroscopic signature for stable beta-amyloid fibrils versus beta-sheet-rich oligomers.","journal-title":"J Phys Chem B"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/jacs.6b05129","volume":"138","author":"Colvin M.T.","year":"2016","unstructured":"Colvin MT, Silvers R, Ni QZ, Can TV, Sergeyev I, Rosay M, Donovan KJ, Michael B, Wall J, Linse S, Griffin RG. Atomic resolution structure of monomorphic a beta(42) amyloid fibrils.","journal-title":"J Am Chem Soc"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2013.08.035","volume":"154","author":"Lu J.X.","year":"2013","unstructured":"Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko R. Molecular structure of beta-amyloid fibrils in Alzheimer\u2019s disease brain tissue.","journal-title":"Cell"},{"key":"ref=152","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1073\/pnas.1600749113","volume":"113","author":"Walti M.A.","year":"2016","unstructured":"Walti MA, Ravotti F, Arai H, Glabe CG, Wall JS, Bockmann A, Guntert P, Meier BH, Riek R. Atomic-resolution structure of a disease-relevant A beta(1-42) amyloid fibril.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"17342","DOI":"10.1073\/pnas.0506723102","volume":"102","author":"Luhrs T.","year":"2005","unstructured":"Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Doeli H, Schubert D, Riek R. 3D structure of Alzheimer\u2019s amyloid-beta(1-42) fibrils.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=154","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/ijms19020571","volume":"19","author":"Grasso G.","year":"2018","unstructured":"Grasso G, Rebella M, Muscat S, Morbiducci U, Tuszynski J, Danani A, Deriu MA. Conformational dynamics and stability of U-shaped and s-shaped amyloid beta assemblies.","journal-title":"Int J Mol Sci"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature20814","volume":"541","author":"Qiang W.","year":"2017","unstructured":"Qiang W, Yau WM, Lu JX, Collinge J, Tycko R. Structural variation in amyloid-beta fibrils from Alzheimer\u2019s disease clinical subtypes.","journal-title":"Nature"},{"key":"ref=156","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1073\/pnas.1524807113","volume":"113","author":"Watanabe-Nakayama T.","year":"2016","unstructured":"Watanabe-Nakayama T, Ono K, Itami M, Takahashi R, Teplow DB, Yamada M. High-speed atomic force microscopy reveals structural dynamics of amyloid beta1-42 aggregates.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=157","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/brain\/awv006","volume":"138","author":"Cohen M.L.","year":"2015","unstructured":"Cohen ML, Kim C, Haldiman T, ElHag M, Mehndiratta P, Pichet T, Lissemore F, Shea M, Cohen Y, Chen W, Blevins J, Appleby BS, Surewicz K, Surewicz WK, Sajatovic M, Tatsuoka C, Zhang SL, Mayo P, Butkiewicz M, Haines JL, Lerner AJ, Safar JG. Rapidly progressive Alzheimer\u2019s disease features distinct structures of amyloid-beta.","journal-title":"Brain"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.4161\/cc.8.11.8503","volume":"8","author":"Treusch S.","year":"2009","unstructured":"Treusch S, Cyr DM, Lindquist S. Amyloid deposits: Protection against toxic protein species?","journal-title":"Cell Cycle"},{"key":"ref=159","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fnins.2017.00064","volume":"11","author":"Stroo E.","year":"2017","unstructured":"Stroo E, Koopman M, Nollen EA, Mata-Cabana A. Cellular regulation of amyloid formation in aging and disease.","journal-title":"Front Neurosci"},{"key":"ref=160","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.celrep.2015.05.021","volume":"11","author":"Liu P.","year":"2015","unstructured":"Liu P, Reed MN, Kotilinek LA, Grant MK, Forster CL, Qiang W, Shapiro SL, Reichl JH, Chiang AC, Jankowsky JL, Wilmot CM, Cleary JP, Zahs KR, Ashe KH. Quaternary structure defines a large class of amyloid-beta oligomers neutralized by sequestration.","journal-title":"Cell Reports"},{"key":"ref=161","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1073\/pnas.1803539115","volume":"115","author":"Yang X.","year":"2018","unstructured":"Yang X, Meisl G, Frohm B, Thulin E, Knowles TPJ, Linse S. On the role of sidechain size and charge in the aggregation of A beta 42 with familial mutations.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1074\/jbc.M116.755264","volume":"292","author":"Hatami A.","year":"2017","unstructured":"Hatami A, Monjazeb S, Milton S, Glabe CG. Familial Alzheimer\u2019s disease mutations within the amyloid precursor protein alter the aggregation and conformation of the amyloid-beta peptide.","journal-title":"J Biol Chem"},{"key":"ref=163","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.1168979","volume":"323","author":"Di Fede G.","year":"2009","unstructured":"Di Fede G, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G, Merlin M, Giovagnoli AR, Prioni S, Erbetta A, Falcone C, Gobbi M, Colombo L, Bastone A, Beeg M, Manzoni C, Francescucci B, Spagnoli A, Cantu L, Del Favero E, Levy E, Salmona M, Tagliavini F. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis.","journal-title":"Science"},{"key":"ref=164","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.WNL.0000042088.22694.E3","volume":"60","author":"Janssen J.C.","year":"2003","unstructured":"Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J. Early onset familial Alzheimer\u2019s disease - Mutation frequency in 31 families.","journal-title":"Neurology"},{"key":"ref=165","first-page":"23184","volume":"285","author":"Ono K.","year":"2010","unstructured":"Ono K, Condron MM, Teplow DB. Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity.","journal-title":"J Biol Chem"},{"key":"ref=166","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/jnnp.2003.010611","volume":"75","author":"Wakutani Y.","year":"2004","unstructured":"Wakutani Y, Watanabe K, Adachi Y, Wada-Isoe K, Urakami K, Ninomiya H, Saido TC, Hashimoto T, Iwatsubo T, Nakashima K. Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer\u2019s disease.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=167","doi-asserted-by":"crossref","first-page":"e35807","DOI":"10.1371\/journal.pone.0035807","volume":"7","author":"Chen W.T.","year":"2012","unstructured":"Chen WT, Hong CJ, Lin YT, Chang WH, Huang HT, Liao JY, Chang YJ, Hsieh YF, Cheng CY, Liu HC, Chen YR, Cheng IH. Amyloid-beta (A beta) D7H mutation increases oligomeric A beta 42 and alters properties of a beta-zinc\/copper assemblies.","journal-title":"PLoS One"},{"key":"ref=168","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/emmm.201100138","volume":"3","author":"Zhou L.","year":"2011","unstructured":"Zhou L, Brouwers N, Benilova I, Vandersteen A, Mercken M, Van Laere K, Van Damme P, Demedts D, Van Leuven F, Sleegers K, Broersen K, Van Broeckhoven C, Vandenberghe R, De Strooper B. Amyloid precursor protein mutation E682K at the alternative beta-secretase cleavage beta '-site increases A beta generation.","journal-title":"EMBO Mol Med"},{"key":"ref=169","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng0692-218","volume":"1","author":"Hendriks L.","year":"1992","unstructured":"Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin JJ. et al.Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.","journal-title":"Nat Genet"},{"key":"ref=170","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"Nilsberth C.","year":"2001","unstructured":"Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Naslund J, Lannfelt L. The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation.","journal-title":"Nat Neurosci"},{"key":"ref=171","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.2111584","volume":"248","author":"Levy E.","year":"1990","unstructured":"Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, Luyendijk W, Frangione B. Mutation of the Alzheimer\u2019s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.","journal-title":"Science"},{"key":"ref=172","doi-asserted-by":"crossref","first-page":"27110","DOI":"10.1016\/S0021-9258(19)61486-9","volume":"275","author":"Miravalle L.","year":"2000","unstructured":"Miravalle L, Tokuda T, Chiarle R, Giaccone G, Bugiani O, Tagliavini F, Frangione B, Ghiso J. Substitutions at codon 22 of Alzheimer\u2019s A beta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.","journal-title":"J Biol Chem"},{"key":"ref=173","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.1009","volume":"49","author":"Grabowski T.J.","year":"2001","unstructured":"Grabowski TJ, Cho HS, Vonsattel JPG, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy.","journal-title":"Ann Neurol"},{"key":"ref=174","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0002-9440(10)64207-1","volume":"161","author":"Kumar-Singh S.","year":"2002","unstructured":"Kumar-Singh S, Cras P, Wang R, Kros JM, van Swieten J, Lubke U, Ceuterick C, Serneels S, Vennekens K, Timmermans JP, Van Marck E, Martin JJ, van Duijn CM, Van Broeckhoven C. Dense-core senile plaques in the Flemish variant of Alzheimer\u2019s disease are vasocentric.","journal-title":"Am J Pathol"},{"key":"ref=175","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/brain\/123.10.2130","volume":"123","author":"Roks G.","year":"2000","unstructured":"Roks G, Van Harskamp F, De Koning I, Cruts M, De Jonghe C, Kumar-Singh S, Tibben A, Tanghe H, Niermeijer MF, Hofman A, Van Swieten JC, Van Broeckhoven C, Van Duijn CM. Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692).","journal-title":"Brain"},{"key":"ref=176","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1248\/bpb.b15-00466","volume":"38","author":"Yagi-Utsumi M.","year":"2015","unstructured":"Yagi-Utsumi M, Dobson CM. Conformational effects of the A21G flemish mutation on the aggregation of amyloid beta peptide.","journal-title":"Biol Pharm Bull"},{"key":"ref=177","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.21321","volume":"63","author":"Tomiyama T.","year":"2008","unstructured":"Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, Takuma H, Kuwano R, Imagawa M, Ataka S, Wada Y, Yoshioka E, Nishizaki T, Watanabe Y, Mori H. A new amyloid mu variant favoring oligomerization in Alzheimer\u2019s-type dementia.","journal-title":"Ann Neurol"},{"key":"ref=178","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/ana.20571","volume":"58","author":"Obici L.","year":"2005","unstructured":"Obici L, Demarchi A, de Rosa G, Bellotti V, Marciano S, Donadei S, Arbustini E, Palladini G, Diegoli M, Genovese E, Ferrari G, Coverlizza S, Merlini G. A novel A beta PP mutation exclusively associated with cerebral amyloid angiopathy.","journal-title":"Ann Neurol"},{"key":"ref=179","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"De Strooper B.","year":"2016","unstructured":"De Strooper B, Karran E. The cellular phase of Alzheimer\u2019s disease.","journal-title":"Cell"},{"key":"ref=180","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1002\/elps.201200297","volume":"33","author":"Penke B.","year":"2012","unstructured":"Penke B, Toth AM, Foldi I, Szucs M, Janaky T. Intraneuronal beta-amyloid and its interactions with proteins and subcellular organelles.","journal-title":"Electrophoresis"},{"key":"ref=181","unstructured":"33(4), 833.el-833.e25"},{"key":"ref=182","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/bi981874p","volume":"38","author":"Schneider A.","year":"1999","unstructured":"Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.","journal-title":"Biochemistry"},{"key":"ref=183","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0002-9440(10)62486-8","volume":"166","author":"Tanimukai H.","year":"2005","unstructured":"Tanimukai H, Grundke-Iqbal I, Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer\u2019s disease.","journal-title":"Am J Pathol"},{"key":"ref=184","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","volume":"18","author":"Wang Y.P.","year":"2009","unstructured":"Wang YP, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, Mandelkow EM, Cuervo AM, Mandelkow E. Tau fragmentation, aggregation and clearance: The dual role of lysosomal processing.","journal-title":"Hum Mol Genet"},{"key":"ref=185","doi-asserted-by":"crossref","first-page":"24978","DOI":"10.1074\/jbc.M501565200","volume":"280","author":"Mukrasch M.D.","year":"2005","unstructured":"Mukrasch MD, Biernat J, von Bergen M, Griesinger C, Mandelkow E, Zweckstetter M. Sites of tau important for aggregation populate beta-structure and bind to microtubules and polyanions.","journal-title":"J Biol Chem"},{"key":"ref=186","doi-asserted-by":"crossref","first-page":"27302","DOI":"10.1074\/jbc.M110.145318","volume":"285","author":"Wegmann S.","year":"2010","unstructured":"Wegmann S, Jung YJ, Chinnathambi S, Mandelkow EM, Mandelkow E, Muller DJ. Human tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability.","journal-title":"J Biol Chem"},{"key":"ref=187","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fnins.2018.00441","volume":"12","author":"Perez M.J.","year":"2018","unstructured":"Perez MJ, Jara C, Quintanilla RA. Contribution of tau pathology to mitochondrial impairment in neurodegeneration.","journal-title":"Front Neurosci"},{"key":"ref=188","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12929-018-0457-x","volume":"25","author":"Chang H.Y.","year":"2018","unstructured":"Chang HY, Sang TK, Chiang AS. Untangling the Tauopathy for Alzheimer\u2019s disease and parkinsonism.","journal-title":"J Biomed Sci"},{"key":"ref=189","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.bbadis.2018.07.011","volume":"1864","author":"Cieri D.","year":"2018","unstructured":"Cieri D, Vicario M, Vallese F, D\u2019Orsi B, Berto P, Grinzato A, Catoni C, De Stefani D, Rizzuto R, Brini M, Cali T. Tau localises within mitochondrial sub-compartments and its caspase cleavage affects ER-mitochondria interactions and cellular Ca2+ handling.","journal-title":"Basis Dis"},{"key":"ref=190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","volume":"99","author":"Ittner A.","year":"2018","unstructured":"Ittner A, Ittner LM. Dendritic tau in Alzheimer\u2019s disease.","journal-title":"Neuron"},{"key":"ref=191","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"Ittner L.M.","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi MA, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models.","journal-title":"Cell"},{"key":"ref=192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt155","volume":"5","author":"Lam B.","year":"2013","unstructured":"Lam B, Masellis M, Freedman M, Stuss DT, Black SE. Clinical, imaging, and pathological heterogeneity of the Alzheimer\u2019s disease syndrome.","journal-title":"Alzheimers Res Ther"},{"key":"ref=193","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/bmm.09.91","volume":"4","author":"Reiman E.M.","year":"2010","unstructured":"Reiman EM, Langbaum JBS, Tariot PN. Alzheimer\u2019s prevention initiative: A proposal to evaluate presymptomatic treatments as quickly as possible.","journal-title":"Biomarkers Med"},{"key":"ref=194","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","volume":"14","author":"Villemagne V.L.","year":"2018","unstructured":"Villemagne VL, Dore V, Burnham SC, Masters CL, Rowe CC. Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions.","journal-title":"Nat Rev Neurol"},{"key":"ref=195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"Kantarci K.","year":"2017","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR, Petersen RC. AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies.","journal-title":"Ann Neurol"},{"key":"ref=196","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"Fagan A.M.","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM. Inverse relation between amyloid imaging load and cerebrospinal fluid Abeta42 in humans.","journal-title":"Ann Neurol"},{"key":"ref=197","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"Morris J.C.","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.","journal-title":"Ann Neurol"},{"key":"ref=198","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","volume":"133","author":"Jack C.R.","year":"2010","unstructured":"Jack CR, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease.","journal-title":"Brain"},{"key":"ref=199","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"Nakamura A.","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dore V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, Iwamoto S, Ito K, Tanaka K, Masters CL, Yanagisawa K. High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease.","journal-title":"Nature"},{"key":"ref=200","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.15252\/emmm.201708763","volume":"10","author":"Nabers A.","year":"2018","unstructured":"Nabers A, Perna L, Lange J, Mons U, Schartner J, Guldenhaupt J, Saum KU, Janelidze S, Holleczek B, Rujescu D, Hansson O, Gerwert K, Brenner H. Amyloid blood biomarker detects Alzheimer\u2019s disease.","journal-title":"EMBO Mol Med"},{"key":"ref=201","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/BJ20120653","volume":"446","author":"Teich A.F.","year":"2012","unstructured":"Teich AF, Arancio O. Is the amyloid hypothesis of Alzheimer\u2019s disease therapeutically relevant?","journal-title":"Biochem J"},{"key":"ref=202","doi-asserted-by":"crossref","first-page":"16485","DOI":"10.1074\/jbc.R116.714576","volume":"291","author":"Luo J.H.","year":"2016","unstructured":"Luo JH, Warmlander SKTS, Graslund A, Abrahams JP. Cross-interactions between the Alzheimer disease amyloid-beta peptide and other amyloid proteins: A further aspect of the amyloid cascade hypothesis.","journal-title":"J Biol Chem"},{"key":"ref=203","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbrc.2016.09.062","volume":"483","author":"Salazar S.V.","year":"2017","unstructured":"Salazar SV, Strittmatter SM. Cellular prion protein as a receptor for amyloid-beta oligomers in Alzheimer\u2019s disease.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=204","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pneurobio.2018.05.001","volume":"168","author":"Jembrek M.J.","year":"2018","unstructured":"Jembrek MJ, Slade N, Hof PR, Simic G. The interactions of p53 with tau and A beta as potential therapeutic targets for Alzheimer\u2019s disease.","journal-title":"Prog Neurobiol"},{"key":"ref=205","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(00)81109-5","volume":"24","author":"Mesulam M.M.","year":"1999","unstructured":"Mesulam MM. Neuroplasticity failure in Alzheimer\u2019s disease: Bridging the gap between plaques and tangles.","journal-title":"Neuron"},{"key":"ref=206","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","volume":"29","author":"Kuperstein I.","year":"2010","unstructured":"Kuperstein I, Broersen K, Benilova I, Rozenski J, Jonekheere W, Debulpaep M, Vandersteen A, Segers-Nolten I, Van der Werf K, Subramaniam V, Braeken D, Callewaert G, Bartic C, D\u2019Hooge R, Martins IC, Rousseau F, Schymkowitz J, De Strooper B. Neurotoxicity of Alzheimer\u2019s disease A beta peptides is induced by small changes in the A beta(42) to A beta(40) ratio.","journal-title":"EMBO J"},{"key":"ref=207","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1084\/jem.20150892","volume":"212","author":"Szaruga M.","year":"2015","unstructured":"Szaruga M, Veugelen S, Benurwar M, Lismont S, Sepulveda-Falla D, Lleo A, Ryan NS, Lashley T, Fox NC, Murayama S, Gijsen H, De Strooper B, Chavez-Gutierrez L. Qualitative changes in human gamma-secretase underlie familial Alzheimer\u2019s disease.","journal-title":"J Exp Med"},{"key":"ref=208","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-biochem-060614-033955","volume":"84","author":"Labbadia J.","year":"2015","unstructured":"Labbadia J, Morimoto RI. The biology of proteostasis in aging and disease.","journal-title":"Annu Rev Biochem"},{"key":"ref=209","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"Crary J.F.","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL, Wisniewski T, Woltjer RL, Yamada M, Nelson PT. Primary age-related tauopathy (PART): a common pathology associated with human aging.","journal-title":"Acta Neuropathol"},{"key":"ref=210","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nn.3606","volume":"17","author":"Khan U.A.","year":"2014","unstructured":"Khan UA, Liu L, Provenzano FA, Berman DE, Profaci CP, Sloan R, Mayeux R, Duff KE, Small SA. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease.","journal-title":"Nat Neurosci"},{"key":"ref=211","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"Karran E.","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics.","journal-title":"Nat Rev Drug Discov"},{"key":"ref=212","doi-asserted-by":"crossref","first-page":"5281829","DOI":"10.1155\/2017\/5281829","volume":"2017","author":"Pignataro A.","year":"2017","unstructured":"Pignataro A, Middei S. Trans-synaptic spread of amyloid-beta in Alzheimer\u2019s disease: Paths to beta-amyloidosis.","journal-title":"Neural Plast"},{"key":"ref=213","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fncel.2018.00172","volume":"12","author":"Perea J.R.","year":"2018","unstructured":"Perea JR, Llorens-Martin M, Avila J, Bolos M. The role of microglia in the spread of tau: relevance for tauopathies.","journal-title":"Front Cell Neurosci"},{"key":"ref=214","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nicl.2017.09.016","volume":"17","author":"Iaccarino L.","year":"2018","unstructured":"Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O\u2019Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer\u2019s Disease.","journal-title":"Neuroimage Clin"},{"key":"ref=215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbpa.2018.05.018","volume":"44","author":"Scannevin R.H.","year":"2018","unstructured":"Scannevin RH. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.","journal-title":"Curr Opin Chem Biol"},{"key":"ref=216","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nrd.2016.281","volume":"16","author":"Mullard A.","year":"2017","unstructured":"Mullard A. Alzheimer amyloid hypothesis lives on.","journal-title":"Nat Rev Drug Discov"},{"key":"ref=217","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","volume":"3","author":"Cummings J.","year":"2017","unstructured":"Cummings J, Lee G, Mortsdorf T, Ritter A, Zhong K. Alzheimer\u2019s disease drug development pipeline: 2017.","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref=218","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","volume":"4","author":"Cummings J.","year":"2018","unstructured":"Cummings J, Lee G, Ritter A, Zhong K. Alzheimer\u2019s disease drug development pipeline: 2018.","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref=219","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2018.02.035","volume":"148","author":"Kumar D.","year":"2018","unstructured":"Kumar D, Ganeshpurkar A, Kumar D, Modi G, Gupta SK, Singh SK. Secretase inhibitors for the treatment of Alzheimer\u2019s disease: Long road ahead.","journal-title":"Eur J Med Chem"},{"key":"ref=220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/ph11010012","volume":"11","author":"Peron R.","year":"2018","unstructured":"Peron R, Vatanabe IP, Manzine PR, Camins A, Cominetti MR. Alpha-secretase ADAM10 regulation: Insights into Alzheimer\u2019s disease treatment.","journal-title":"Pharmaceuticals"},{"key":"ref=221","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","volume":"83","author":"van Dyck C.H.","year":"2018","unstructured":"van Dyck CH. Anti-amyloid-beta monoclonal antibodies for Alzheimer\u2019s disease: Pitfalls and promise.","journal-title":"Biol Psychiatry"},{"key":"ref=222","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/alzrt246","volume":"6","author":"Lannfelt L.","year":"2014","unstructured":"Lannfelt L, Moller C, Basun H, Osswald G, Sehlin D, Satlin A, Logovinsky V, Gellerfors P. Perspectives on future Alzheimer therapies: Amyloid-beta protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer\u2019s disease.","journal-title":"Alzheimers Res Ther"},{"key":"ref=223","unstructured":""},{"key":"ref=224","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/13543784.2017.1313832","volume":"26","author":"Parsons C.G.","year":"2017","unstructured":"Parsons CG, Rammes G. Preclinical to phase II amyloid beta (A) peptide modulators under investigation for Alzheimer\u2019s disease.","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"Congdon E.E.","year":"2018","unstructured":"Congdon EE, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease.","journal-title":"Nat Rev Neurol"},{"key":"ref=226","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/brainsci8090162","volume":"8","author":"Khan R.I.","year":"2018","unstructured":"Khan RI, Nirzhor SSR, Rashid B. A closer look into the role of protein Tau in the identification of promising therapeutic targets for Alzheimer\u2019s disease.","journal-title":"Brain Sci"},{"key":"ref=227","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3390\/ijms19041160","volume":"19","author":"Medina M.","year":"2018","unstructured":"Medina M. An overview on the clinical development of tau-based therapeutics.","journal-title":"Int J Mol Sci"},{"key":"ref=228","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jep.2017.12.015","volume":"6","author":"Sahoo A.K.","year":"2018","unstructured":"Sahoo AK, Dandapat J, Dash UC, Kanhar S. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer\u2019s disease.","journal-title":"J Ethnopharmacol"},{"key":"ref=229","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4103\/1673-5374.239433","volume":"13","author":"Zhang Z.","year":"2018","unstructured":"Zhang Z, Nie S, Chen L. Targeting prion-like protein spreading in neurodegenerative diseases.","journal-title":"Neural Regen Res"},{"key":"ref=230","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3233\/JAD-150860","volume":"53","author":"Kasza A.","year":"2016","unstructured":"Kasza A, Hunya A, Frank Z, Fulop F, Torok Z, Balogh G, Santha M, Bernath S, Blundell KLIM, Prodromou C, Horvath I, Zeiler HJ, Hooper PL, Vigh L, Penke B. Dihydropyridine derivatives modulate heat shock responses and have a neuroprotective effect in a transgenic mouse model of Alzheimer\u2019s disease.","journal-title":"J Alzheimers Dis"},{"key":"ref=231","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jalz.2013.05.1762","volume":"9","author":"Carrillo M.C.","year":"2013","unstructured":"Carrillo MC, Dean RA, Nicolas F, Miller DS, Berman R, Khachaturian Z, Bain LJ, Schindler R, Knopman D. Revisiting the framework of the National Institute on Aging-Alzheimer\u2019s Association diagnostic criteria.","journal-title":"Alzheimers Dement"},{"key":"ref=232","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ncl.2016.06.009","volume":"34","author":"Hickman R.A.","year":"2016","unstructured":"Hickman RA, Faustin A, Wisniewski T. Alzheimer disease and its growing epidemic risk factors, biomarkers, and the urgent need for therapeutics.","journal-title":"Neurol Clin"},{"key":"ref=233","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"Sweeney M.D.","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.","journal-title":"Nat Rev Neurol"},{"key":"ref=234","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/WNL.43.6.1254","volume":"43","author":"Peacock M.L.","year":"1993","unstructured":"Peacock ML, Warren JT, Roses AD, Fink JK. Novel polymorphism in the a4-region of the amyloid precursor protein gene in a patient without Alzheimers-disease.","journal-title":"Neurology"},{"key":"ref=235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4161\/fly.20999","volume":"6","author":"Petersen A.J.","year":"2012","unstructured":"Petersen AJ, Wassarman DA. Drosophila innate immune response pathways moonlight in neurodegeneration.","journal-title":"Fly"},{"key":"ref=236","first-page":"998","volume":"51","author":"Kamino K.","year":"1992","unstructured":"Kamino K, Orr HT, Payami H, Wijsman EM, Alonso ME, Pulst SM, Anderson L, Odahl S, Nemens E, White JA, Sadovnick AD, Ball MJ, Kaye J, Warren A, Mcinnis M, Antonarakis SE, Korenberg JR, Sharma V, Kukull W, Larson E, Heston LL, Martin GM, Bird TD, Schellenberg GD. Linkage and mutational analysis of familial Alzheimer-disease kindreds for the APP gene region.","journal-title":"Am J Hum Genet"}],"container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/168738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T17:09:10Z","timestamp":1662743350000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/168738\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":236,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,5,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389203720666190103123434","relation":{},"ISSN":["1389-2037"],"issn-type":[{"value":"1389-2037","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}